Medroxyprogesterone acetate - Contraception

You are here : Home > Formulary Search > Medroxyprogesterone acetate - Contraception

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green

Formulations :

Injection

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

Guidelines BNF SPC

Restrictions / Comments :

Important

Sayana Press

Patients may be trained to self-administer Sayana Press

Status 2

Green (see narrative)

Formulations :

Pre-filled syringe

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

Guidelines BNF SPC

Restrictions / Comments :

Important

Depo Provera

CSM advice: Depo-Provera should only be used when other methods of contraception are inappropriate. Benefits of using medroxyprogesterone acetate beyond 2 years should be evalated against risk.

Women with risk factors for osteoporosis should consider alternative methos of contraception.

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Medroxyprogesterone acetate

Indication :

Contraception

Group Name :

Keywords :

progestogen only

Brand Names Include :

Depo-Provera 150mg/1ml pre-filled syringe, Sayana Press 104mg/0.65ml

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Contraception

Supporting Documents :

Traffic Light Entries :

Other Indications

Below are listed other indications that Medroxyprogesterone acetate is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Contraception.

Committee Recommendations (1)

01 Jan 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.